An observational study in Takayasu Arteritis With Pulmonary Artery Involvement, Percutaneous Transluminal Pulmonary Angioplasty and PAH Targeted Medication, sponsored by Chinese Pulmonary Vascular Disease Research Group. Recruiting at 1 site in China. Per ClinicalTrials.gov, last updated 2026-09-22.
Sponsored by Chinese Pulmonary Vascular Disease Research Group · Observational
At baseline, FAPI and FDG are performed to evaluate the activity of takayasu arteritis with pulmonary artery involvement. FAPI is also used to predict the treatment efficacy and prognosis of takayasu arteritis with pulmonary artery involvement.
Chinese Pulmonary Vascular Disease Research Group is the lead sponsor of 16 studies on the registry; 10 are open to participants now.
Counted across the registry records on this site, refreshed daily.
patients diagnosed with Takayasu arteries with pulmonary arteries involvement received either medical or percutaneous transluminal pulmonary angioplasty
Exclusion Criteria:
Percutaneous transluminal pulmonary angioplasty
all cause death
all cause death
Time frame: 2014/1/1-2042/12/31
mean pulmonary arterial pressure change
change of mean pulmonary arterial pressure after treatment
Time frame: 2014/1/1-2042/12/31
pulmonary vascular resistance change
chagne of pulmonary vascular resistance after treatment
Time frame: 2014/1/1-2042/12/31
6MWD change
change of six minute walk distance after treatment
Time frame: 2014/1/1-2042/12/31
peak VO2 change
change of peak oxygen consumption after treatment
Time frame: 2014/1/1-2042/12/31
NT-proBNP change
change of NT-proBNP after treatment
Time frame: 2014/1/1-2042/12/31
RV/LV change
change of right ventricular end-diastolic diameter versus laboratory left ventricular end-diastolic diameterafter treatment
Time frame: 2014/1/1-2042/12/31
CI change
change of cardiac index after treatment
Time frame: 2014/1/1-2042/12/31
Plan to share: No
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Chinese Pulmonary Vascular Disease Research Group